Latest Buck Institute for Age Research Stories
Lithium profoundly prevents the aggregation of toxic proteins and cell loss associated with Parkinson's disease (PD) in a mouse model of the condition.
Basic Yellow 1, a dye used in neuroscience laboratories around the world to detect damaged protein in Alzheimer's disease, is a wonder drug for nematode worms.
Researchers at the Buck Institute for Age Research have discovered a novel way in which insulin affects cell metabolism and cell survival.
Rodent study highlights need for human clinical trials of drugs shown to increase growth of new neurons.
Research spearheaded at Buck Institute results in a web-based tool available to other scientists.
Flies fed an "anti-Atkins" low protein diet live longer because their mitochondria function better.
When cells experiencing DNA damage fail to repair themselves, they send a signal to their neighbors letting them know they're in trouble.
SALT LAKE CITY, March 13 /PRNewswire/ -- Prolexys Pharmaceuticals announced today the publication of the discovery of genes that are likely to have a role in the aging process of humans.
By Richard Halstead, The Marin Independent Journal, Novato, Calif. Aug.
Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, has licensed an engineered stem cell line from the Buck Institute for Age Research. The stem cell line is used in the study of neural cells in neurodegenerative disease.
- A woman chauffeur.
- A woman who operates an automobile.